Related Experiment Video
Updated: Jul 11, 2026
15:33
Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
Published on: August 13, 2013
Transductional targeting with recombinant adenovirus vectors
Valerie Legrand1, Philippe Leissner, Arend Winter
1TRANSGENE S.A., 11 rue de Molsheim, 67085 Strasbourg, France. vlegrand@carex.fr
Current Gene Therapy
|August 23, 2002
Summary
Replication-deficient adenoviruses offer broad gene delivery but can harm normal tissues. Strategies to restrict viral tropism enhance safety and efficiency for gene therapy, especially in cancer treatment.
Area of Science:
- Biotechnology
- Molecular Biology
- Gene Therapy
Background:
- Replication-deficient adenoviruses are promising gene delivery vectors for treating various diseases.
- Their broad tissue tropism enables efficient gene expression in diverse cell types.
- However, this broad tropism poses risks when delivering genes for harmful proteins to normal tissues.
Purpose of the Study:
- To review strategies for selectively modifying the natural tropism of recombinant adenoviruses.
- To discuss the advantages, limitations, and impact of these modified vectors on gene therapy.
Main Methods:
- Review of existing literature on tropism modification strategies for adenoviral vectors.
- Analysis of techniques used to restrict viral tropism.
Main Results:
- Various strategies exist to selectively alter adenoviral tropism.
- These modifications aim to enhance targeting specificity and reduce off-target effects.
- The review discusses the implications of these modified vectors for gene therapy.
Conclusions:
- Modifying adenoviral tropism is crucial for safer and more effective gene delivery.
- Targeted tropism restriction is particularly important for cancer gene therapy.
- Further research into these modified vectors will advance gene therapy applications.
